CTMX

CYTOMX THERAPEUTICS INC.

CTMX·23284F105·US·Common Stock·Healthcare - Biotechnology-13D/G

CTMX (CYTOMX THERAPEUTICS INC.) is held by 104 institutional investors as of Q2 2026. Largest holders: FMR LLC ($122.7M), BlackRock, Inc. ($65.8M), BANK OF AMERICA CORP /DE/ ($56.6M). Net institutional sentiment: Mixed.

104
Holders
(4 Elite)
$556M
Total Value
63% (117)
Consensus
74 buying - 43 selling
13F: Insider & Congress: Updated regularly
CTMX

Smart Money Verdict

View all
Loading verdict
Held by 104 funds
4 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Mar 19, 2026 · Activists Aug 14, 2026 · Congress none

ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.3.6%Aug 14, 2026
ActivistKYKynam Capital Management, LP10.0%Aug 14, 2026
ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION5.4%Aug 7, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
32.7M(+2.4%)$122.7M0.0%-7.17%
31
Increased
17.6M(+235.9%)$65.8M0.0%-7.50%
48
Increased
15.1M(+47.8%)$56.6M0.0%-24.11%
40
Increased
11.7M(+107.4%)$44.1M0.0%-13.78%
47
Decreased
8.5M(-2.4%)$32M0.0%-30.98%
0
Decreased
7.8M(-0.8%)$29.3M0.0%+4.19%
0
Increased
5.2M(+44.3%)$19.4M0.0%-25.97%
38
Unchanged
5M$18.7M0.1%+19.68%
0
Increased
4.7M(+126.4%)$17.5M0.0%-19.57%
46
Increased
4.1M(+52.5%)$15.5M0.0%-16.57%
39
Increased
3.5M(+11.2%)$13M0.0%-27.92%
31
Decreased
3.1M(-42.5%)$11.7M0.0%-29.47%
0
Decreased
3M(-26.9%)$11.3M0.0%-19.07%
0
Increased
2M(+2.0%)$7.7M0.0%+188.12%
28
Increased
2M(+37.3%)$7.5M0.0%-15.18%
36
Decreased
1.9M(-3.7%)$7M0.0%-18.34%
0
Decreased
1.8M(-18.9%)$6.8M0.0%-25.44%
0
Increased
1.8M(+120.3%)$6.6M0.0%-21.53%
44
Decreased
1.7M(-53.9%)$6.3M0.0%-28.76%
0
Increased
1.7M(+173.7%)$6.3M0.0%-15.56%
44

Showing 1-20 of 123

1 / 7
CTMXCTMXCYTOMX THERAPEUTICS INC.

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used